Sleep duration trajectories and systemic inflammation in young adults: Results from the national longitudinal study of adolescent to adult health (add health)

Sleep

Volumn 40, Issue 11, 2017, Pages

  Bakour, Chighaf ^a   Schwartz, Skai ^a   O'Rourke, Kathleen ^a   Wang, Wei ^a   Sappenfield, William ^a   Couluris, Marisa ^b   Chen, Henian ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Inflammation; Sleep duration; Trajectories; Young adults

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ADOLESCENT; ADOLESCENT HEALTH; ADULT; FEMALE; HEALTH SURVEY; HUMAN; INFLAMMATION; LONGITUDINAL STUDY; MALE; METABOLISM; PHYSIOLOGY; SEXUAL CHARACTERISTICS; SLEEP; TIME FACTOR; YOUNG ADULT;

ADOLESCENT; ADOLESCENT HEALTH; ADULT; BIOMARKERS; C-REACTIVE PROTEIN; FEMALE; HEALTH SURVEYS; HUMANS; INFLAMMATION; LONGITUDINAL STUDIES; MALE; SEX CHARACTERISTICS; SLEEP; TIME FACTORS; YOUNG ADULT;

EID: 85044517957     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.1093/sleep/zsx156     Document Type: Article

References (34)

1. Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report.Unhealthy Sleep-Related Behaviors-12 States, 2009.; 2011. http://www.cdc.gov/mmwr/PDF/wk/mm6008.pdf. Accessed March 8, 2015.
2. Miller MA, Cappuccio FP. Sleep, Inflammation, and Disease. Aetiology to Public Health; 2010:1-34. doi:10.1093/acprof.
3. Martinez-Gomez D, Eisenmann JC, Gomez-Martinez S, et al.; AFINOS Study Group. Sleep duration and emerging cardiometabolic risk markers in adolescents. The AFINOS study. Sleep Med. 2011; 12(10): 997-1002.
4. Ferrie JE, Kivimäki M, Akbaraly TN, et al. Associations between change in sleep duration and inflammation: Findings on C-reactive protein and interleukin 6 in the Whitehall II Study. Am J Epidemiol. 2013; 178(6): 956-961.
5. Grandner MA, Buxton OM, Jackson N, Sands-Lincoln M, Pandey A, Jean-Louis G. Extreme sleep durations and increased C-reactive protein: Effects of sex and ethnoracial group. Sleep. 2013; 36(5): 769-779E.
6. Dowd JB, Goldman N, Weinstein M. Sleep duration, sleep quality, and biomarkers of inflammation in a Taiwanese population. Ann Epidemiol. 2011; 21(11): 799-806.
7. Grandner MA, Sands-Lincoln MR, Pak VM, Garland SN. Sleep duration, cardiovascular disease, and proinflammatory biomarkers. Nat Sci Sleep. 2013; 5: 93-107.
8. Patel SR, Zhu X, Storfer-Isser A, et al. Sleep duration and biomarkers of inflammation. Sleep. 2009; 32(2): 200-204.
9. Williams CJ, Hu FB, Patel SR, Mantzoros CS. Sleep duration and snoring in relation to biomarkers of cardiovascular disease risk among women with type 2 diabetes. Diabetes Care. 2007; 30(5): 1233-1240.
10. Okun ML, Coussons-Read M, Hall M. Disturbed sleep is associated with increased C-reactive protein in young women. Brain Behav Immun. 2009; 23(3): 351-354.
11. Miller MA, Kandala NB, Kivimaki M, et al. Gender differences in the cross-sectional relationships between sleep duration and markers of inflammation: Whitehall II study. Sleep. 2009; 32(7): 857-864./pmc/articles/PMC2706900/?report=abstract. Accessed July 31, 2014.
12. Cho HJ, Seeman TE, Kiefe CI, Lauderdale DS, Irwin MR. Sleep disturbance and longitudinal risk of inflammation: Moderating influences of social integration and social isolation in the Coronary Artery Risk Development in Young Adults (CARDIA) study. Brain Behav Immun. 2015; 46(46): 319-326.
13. Cappuccio FP, Miller MA, Lockley SW. Sleep, Health, and Society: The Contribution of Epidemiology. Aetiology to Public Health series. Oxford, New York: Oxford University Press; 2010.
14. Suarez EC. Self-reported symptoms of sleep disturbance and inflammation, coagulation, insulin resistance and psychosocial distress: Evidence for gender disparity. Brain Behav Immun. 2008; 22(6): 960-968.
15. Zhang S, Liu X, Kim JS, et al. Association between short sleep duration and the risk of sensitization to food and aero allergens in rural Chinese adolescents. Clin Exp Allergy. 2011; 41(4): 547-555.
16. Liukkonen T, Räsänen P, Ruokonen A, et al. C-reactive protein levels and sleep disturbances: Observations based on the Northern Finland 1966 Birth Cohort study. Psychosom Med. 2007; 69(8): 756-761.
17. Whitsel EA, Cuthbertson CC, Tabor JW, et al. Add Health Wave IV Documentation: Measures of Inflammation and Immune Function - Add Health. 2012. http://www.cpc.unc.edu/projects/addhealth/documentation/guides/add-health-wave-iv-documentation-measures-of-inflammation-and-immune-function/view. Accessed May 19, 2016.
18. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease application to clinical and public health practice a statement for healthcare professionals from the centers for disease control and prevention and the American heart association. Circulation. 2003; 107(3):499-511.
19. Stanton CA, Keith DR, Gaalema DE, et al. Trends in tobacco use among US adults with chronic health conditions: National Survey on Drug Use and Health 2005-2013. Prev Med (Baltim). 2016. doi:10.1016/j. ypmed.2016.04.008.
20. Jones BL, Nagin DS, Roeder K. A SAS procedure based on mixture models for estimating developmental trajectories. Sociol Methods Res. 2001; 29(3): 374-393.
21. Nylund KL, Asparouhov T, Muthen BO. Deciding on the number of classes in latent class analysis and growth mixture modeling: A Monte Carlo simulation study. Struct Equ Model A Multidiscip J. 2007; 14(4): 535-569. http://eric.ed.gov/?id=EJ780617. Accessed May 17, 2016.
22. Irwin MR, Olmstead R, Carroll JE. Sleep disturbance, sleep duration, and inflammation: A systematic review and meta-analysis of cohort studies and experimental sleep deprivation. Biol Psychiatry. 2016; 80(1): 40-52.
23. Prather AA, Vogelzangs N, Penninx BW. Sleep duration, insomnia, and markers of systemic inflammation: Results from the Netherlands study of depression and anxiety (NESDA). J Psychiatr Res. 2015; 60 (50): 95-102.
24. Miller MA, Cappuccio FP. Inflammation, sleep, obesity and cardiovascular disease. Curr Vasc Pharmacol. 2007; 5(2):93-102. http://www.ncbi. nlm.nih.gov/pubmed/17430213. Accessed May 23, 2016.
25. Cappuccio FP, Miller MA, Lockley SW. Sleep, Health and Society. Oxford: Oxford University Press; 2010. http://www. oxfordscholarship.com.ezproxy.lib.usf.edu/view/10.1093/acprof: Oso/9780199566594.001.0001/acprof-9780199566594.
26. Gursoy AY, Caglar GS, Kiseli M, Pabuccu E, Candar T, Demirtas S. CRP at early follicular phase of menstrual cycle can cause misinterpretation for cardiovascular risk assessment. Interv Med Appl Sci. 2015; 7(4): 143-146.
27. Wander K, Brindle E, O'Connor KA. C-reactive protein across the menstrual cycle. Am J Phys Anthropol. 2008; 136(2): 138-146.
28. Mantua J, Spencer RM. The interactive effects of nocturnal sleep and daytime naps in relation to serum C-reactive protein. Sleep Med. 2015; 16(10): 1213-1216.
29. Gilmour H, Stranges S, Kaplan M, et al. Longitudinal trajectories of sleep duration in the general population. Heal reports. 2013; 24(11): 14-20.
30. Lauderdale DS, Knutson KL, Yan LL, Liu K, Rathouz PJ. Self-reported and measured sleep duration: How similar are they? Epidemiology. 2008; 19(6): 838-845.
31. Biddle DJ, Robillard R, Hermens DF, Hickie IB, Glozier N. Accuracy of self-reported sleep parameters compared with actigraphy in young people with mental ill-health. Sleep Heal. 2015; 1(3): 214-220.
32. Tremaine RB, Dorrian J, Blunden S. Subjective and objective sleep in children and adolescents: Measurement, age, and gender differences. Sleep Biol Rhythms. 2010; 8(4): 229-238.
33. Wolfson AR, Carskadon MA, Acebo C, et al. Evidence for the validity of a sleep habits survey for adolescents. Sleep. 2003; 26(2): 213-216. http://www.ncbi.nlm.nih.gov/pubmed/12683482. Accessed April 19, 2016.
34. Curran PJ, Obeidat K, Losardo D. Twelve frequently asked questions about growth curve modeling. J Cogn Dev. 2010; 11(2): 121-136.